33 results
S-8
EX-99.3
VERV
Verve Therapeutics Inc
27 Feb 24
Registration of securities for employees
8:32am
shall determine the effect on an Award of the disability, death, termination or other cessation of employment, authorized leave of absence or other
8-K
EX-1.1
qsa uvuqch7xvfg0up7
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
13me0awfoxb91
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
dns 5wv4g
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
EX-1.1
rj7ct1i88 q2gb
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
fq8l 2tudbzv
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
7pr1ehryprcawjf60
20 Jul 22
Prospectus supplement for primary offering
4:22pm
DEF 14A
jmz6k91
29 Apr 22
Definitive proxy
7:01am
10-K
EX-10.4
6vaqolzkb6a3r8kh8
14 Mar 22
Annual report
7:04am
10-K
EX-10.19
lrdo8 2u39
14 Mar 22
Annual report
7:04am
424B4
q13gn1
17 Jun 21
Prospectus supplement with pricing info
4:50pm
S-1/A
EX-10.4
m6u76su0 uqv3jy
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
EX-10.5
64dpg
14 Jun 21
IPO registration (amended)
6:15am
S-1/A
EX-10.19
zaxrwr41z nc1f00qfwq
14 Jun 21
IPO registration (amended)
6:15am